Wyss InstituteDiagnostics – Wyss Institute

David Walt named as laureate for National Medal of Technology and Innovation

Jessica Leff — Tue, 07 Jan 2025 14:52:56 +0000

By Benjamin Boettner (BOSTON) — On January 3, Wyss Institute Core Faculty member David Walt, Ph.D., who also is a Professor of Pathology at Boston’s Brigham and Women’s Hospital (BWH), the Hansjörg Wyss Professor of Biologically Inspired Engineering at Harvard Medical School (HMS), an Associate member at the Broad Institute, and a Howard Hughes Medical Institute Professor…

Source

Collaborative asthma project between Brigham and Women’s Hospital and the Wyss Institute advances with new grant support

Jessica Leff — Mon, 16 Dec 2024 15:55:41 +0000

By Benjamin Boettner (BOSTON) – Asthma affects more than 260M people worldwide and nearly 28M people in the U.S. alone, where, on average, 10 people die from attacks of the chronic disease each day. Many of these deaths could be prevented if patients had timely access to the appropriate therapy following an accurate diagnosis. Driven by an acute sense of urgency to close this diagnostic gap…

Source

20-ish Questions with Natalie Artzi

Jessica Leff — Mon, 18 Nov 2024 19:37:29 +0000

20-ish Questions shows a different side of Wyss Institute faculty, touching on aspects of their personal life, hobbies, interests, as well as their research. This round follows Natalie Artzi, a new addition to the Wyss Institute’s Core Faculty. Credit: Wyss Institute at Harvard University…

Source

Closing in on Parkinson’s Disease proteins in extracellular vesicles in the blood

Jessica Leff — Fri, 01 Nov 2024 13:20:38 +0000

By Benjamin Boettner (BOSTON) — Brain disorders like Parkinson’s (PD) or Alzheimer’s Disease (AD) start to develop in patients much earlier than when their first clinical symptoms appear. Treating patients at these early stages could slow or even stop their disease, but there is currently no way to diagnose brain disorders at those pre-symptomatic stages. Thus far, the specific brain lesions…

Source

Starting a fluorescent biosensor revolution

Mariel Schoen — Thu, 05 Sep 2024 09:00:00 +0000

By Benjamin Boettner (BOSTON) — Biosensors – devices that use biological molecules to detect the presence of a target substance – have enormous potential for detecting disease biomarkers, molecules-in-action in diverse biological processes, or toxins and other harmful substances in the environment. One of the more common types, fluorescent biosensors, consists of a target-binding biomolecule…

Source

Wyss Institute promotes Natalie Artzi to its Core Faculty and appoints Di Feng as an Associate Faculty member

Jessica Leff — Mon, 12 Aug 2024 13:15:25 +0000

By Benjamin Boettner (BOSTON) — Natalie Artzi, Ph.D., joined the ranks of the Wyss Institute’s now 12 Core Faculty members after only two years as an Associate Faculty member. Artzi’s promotion reflects her exceptional commitment to the Institute’s mission and the deep engagements and collaborations she has initiated within its technology development community. The Wyss Institute also warmly…

Source

Clarissa May Babila on Using “Packages” from Cells to Diagnose Brain Diseases

Jessica Leff — Mon, 29 Jul 2024 15:05:10 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. When Clarissa May Babila was in elementary school, there was one movie she wanted to watch over and over: a PBS documentary on Rosalind Franklin. That early love for science led her to an…

Source

The Wyss Institute’s 2024-2025 Validation Projects

Jessica Leff — Wed, 29 May 2024 14:55:23 +0000

Every year the Wyss Institute names a class of Validation Projects whose teams receive dedicated funding, business development support, and other resources to advance their promising technologies towards commercialization. They also collaborate with key opinion leaders, investors, and potential customers to de-risk their innovations and speed their progress to the market. This year…

Source

Innovating Diagnostics to Improve Clinical Care and Patient Outcomes

Jessica Leff — Wed, 15 May 2024 17:46:59 +0000

Guest speaker, Sarah-Beth Perullo, shares the immense difficulty she faced in obtaining a diagnosis for her mysterious symptoms. Her story is a sobering reminder of how frequent patient symptoms are dismissed in the medical field. Credit: Wyss Institute at Harvard University…

Source

Instrument-Free Molecular Diagnostics

Mariel Schoen — Wed, 01 May 2024 17:25:23 +0000

Molecular diagnostics is the fastest-growing segment of the global in vitro diagnostics market, but the vast majority of these tests require expensive equipment and supplies, limiting their use to medical facilities. There is a large unmet need for cheap, readily accessible, accurate diagnostic tests that can be deployed in non-clinical settings to address threats to public health…

Source